Leaders in Ion Channel Drug Discovery
Metrion Biosciences is a specialist ion channel contract research organisation providing drug discovery services to pharmaceutical and bioscience customers worldwide.
Metrion invests in new HTS capability and expanded facilities
30 November 2022
Metrion announces the launch of its High Throughput Screening (HTS) capability, as well as the expansion of its state-of-the-art lab and office facilities. Scott Maidment has been appointed as Head of HTS to lead the new service.
Metrion and The KCNC1 Foundation collaborate on development of new ion channel modulators for ultra-rare genetic disorder
7 December 2022
Metrion and The KCNC1 Foundation, a not-for-profit organisation focused on the development of a treatment for an ultra rare genetic disorder, today announced a collaboration to progress a hit identification research project for small molecule modulators of the potassium ion channel Kv3.1, targeting KCNC1-related disorders.
Ion Channel Screening
Cardiac Safety Screening
Integrated Drug Discovery
Metrion Biosciences’ high throughput screening (HTS) overview
6th March 2023
Here we share a short video introducing Metrion’s expanded high throughput screening capabilities. To learn more, or to request a quote, please email email@example.com
- Zeki – From Ants to Ion Channels
- Thomas’s Career So Far
- Katie – Expanding my skills to the world of ion channels
- Catherine’s Career So Far
- Yasmin – About Me
- Professor David Sheppard presents on “Cystic Fibrosis: Rescuing Faulty Channels with Targeted Therapies”
Society of Toxicology Annual Meeting and ToxExpo
March 19th – March 22nd
Metrion Biosciences Chief Commercial Officer, Nick Foster and Senior Scientist II Ray Tang will be attending the conference and will be at booth number 1545. To arrange a meeting with our delegates please email: firstname.lastname@example.org.
The three-day ToxExpo—taking place from 9:00 am to 4:30 pm, March 20–22, 2023—features companies and organizations that support toxicologists and the toxicology community. Exhibitors include research organizations, government agencies, laboratory suppliers, drug developers, consulting firms, and academic institutions.
7th RSC – BMCS / SCI Symposium on Ion Channels as Therapeutic Targets 2023
March 27th -March 28th
Metrion Biosciences is sponsoring and attending the 7th RSC-BMCS / SCI Symposium on Ion Channels as Therapeutic Targets, taking place on 27th and 28th March 2023 at the Wellcome Genome Campus, Hinxton, Cambridge.
Metrion’s Dr Alexandra Pinggera will be presenting at this meeting and if you would to meet with her please email email@example.com.
Metrion will have a booth at the event and we would be delighted if you would stop by to say hello to our Chief Commercial Officer, Nick Foster and Sales and Marketing Manager, Sophie Rose.
Our DisPATCHes Newsletter
Receive the latest Ion Channel news and insights to your inbox
Our quarterly newsletter is packed full of the latest Ion Channel news and reviews. We cover events, webinars, research findings, and publications and insights from our team, partners, and distinguished guests. Read the latest edition here.
Let’s work together
What are your specific ion channel and assay needs?
If you have any questions or would like to discuss your specific assay requirements, we will put you directly in touch with a member of our scientific team. Contact us today to discover more.